ELVN Stock Analysis: Buy, Sell, or Hold?
ELVN - Enliven Therapeutics, Inc. Common Stock
$26.45
0.78 (3.04%)
▲
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Mar 12, 2026
Get Alerted When ELVN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ELVN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: ELVN shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: ELVN is currently trading at $26.45, which is considered slightly high relative to its 30-day fair value range of $16.89 to $26.82.
Technical Outlook: Technically, ELVN is in a uptrend. Immediate support is located at $24.82, while resistance sits at $28.69. The stock is showing strong short-term momentum, up 3.0% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $41.38 (+61.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ELVN is in a uptrend. Immediate support is located at $24.82, while resistance sits at $28.69. The stock is showing strong short-term momentum, up 3.0% recently.
Market Sentiment: The stock shows a mixed technical setup (55/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $41.38 (+61.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Fair Price Range
$16.89 -
$26.82
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.1%
All Signals
- NEUTRAL: Mixed technical signals (55/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.0%)
- BULLISH: Trading 61.2% below Wall St target ($41.38)
Fair Price Analysis
30-Day Fair Range
$16.89 -
$26.82
Current vs Fair Value
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$24.82
Resistance Level
$28.69
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-12.97
Wall Street Target
$41.38
(+61.2%)
Last updated: January 30, 2026 4:05 PM ET
Data refreshes hourly during market hours. Next update: 5:05 PM
Data refreshes hourly during market hours. Next update: 5:05 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ELVN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
18
Sells
Net
INSIDERS SELLING
Recent Transactions
Joseph P Lyssikatos
SELL
12500 shares
2025-10-20
Samuel Kintz
SELL
12500 shares
2025-10-17
Anish Patel
SELL
6667 shares
2025-10-07
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$214 | 60 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$89 | 61 BUY |
Advanced ELVN Option Strategies
Professional options setups generated by AI based on today's ELVN price and gamma walls.
